RedHill Biopharma (RDHL) FCF Margin Growth (3y) (2015 - 2022)
RedHill Biopharma (RDHL) FCF Margin Growth (3y) (2015 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 213.00 |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 2,102.00 |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 180.00 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 1,592.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -291.00 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | -2,476.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1,604.00 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 85,127.00 |
| Sep 30, 2022 | 60,054.00 |
| Jun 30, 2022 | 57,110.00 |
| Mar 31, 2022 | 40,172.00 |
| Dec 31, 2021 | 53,527.00 |
| Sep 30, 2021 | 29,143.00 |
| Jun 30, 2021 | 26,944.00 |
| Mar 31, 2021 | 32,866.00 |
| Dec 31, 2020 | 64,882.00 |
| Sep 30, 2020 | 64,735.00 |
| Jun 30, 2020 | 192,114.00 |
| Mar 31, 2020 | -20.74 Mn |
| Dec 31, 2019 | 926,981.00 |
| Dec 31, 2018 | 800,742.00 |
| Jun 30, 2018 | 46.71 Mn |
| Dec 31, 2017 | 58.94 Mn |
| Sep 30, 2017 | -63,616.00 |
| Jun 30, 2017 | -199,286.00 |
| Mar 31, 2017 | -2.41 Bn |
| Dec 31, 2016 | 23.51 Mn |